BLLN BillionToOne, Inc.
Company Analysis
Latest News
🔴 BillionToOne is trading 7.1% down today despite strong results and raised 2026 outlook
BillionToOne is trading 7.1% down at $105.83 on November 5 after its earnings call, with investors potentially weighing details despite third-quarter revenue...
BillionToOne Crushes Q3 Estimates and Lifts Guidance, but Can a Prenatal Testing Pioneer Sustain This Growth Pace?
Shares of BillionToOne surged 6.0% in pre-market trading to $120.73 after the molecular diagnostics company posted third-quarter results that handily topped...
🟢 BillionToOne is trading 6% up in pre-market after raising 2026 revenue outlook
BillionToOne is trading 6.00% up at $120.73 in pre-market on November 5 after third-quarter revenue rose 47% year over year to $123.0 million, above...
BillionToOne's third quarter 2026 revenue beat estimates as the company raised full-year guidance
BillionToOne reported third quarter 2026 financial results that exceeded analyst expectations on both the top and bottom lines, driven by significant volume...
BillionToOne, Inc. Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
BillionToOne is expected to report Q3 2026 revenue of $116.27 million and EPS of $0.16, with shares currently trading at $114.84 compared to an analyst target...
🔴 BillionToOne is trading 4.04% down — cause unclear
BillionToOne is trading 4.04% down at $108.74, with the reason for the decline unclear. - On November 2, 2026, available search results showed no...
🟢 BillionToOne is trading 4.2% up amid broader biotech-sector strength
BillionToOne is trading 4.2% up at $118.83 on October 28, 2026, amid biotech-sector strength, though no direct cause is established. - The provided sector...
🟢 BillionToOne rises 4.1% — Biotech Sector Rallies on M&A Activity and Anticipation of Key Cancer Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector moved higher, fueled by news that...
🔴 BillionToOne is trading 4.24% down today amid biotech-sector weakness
BillionToOne is trading at $98.37, down 4.24%, with biotech-sector weakness the clearest available context. - No new company-specific announcement explaining...
🟢 BillionToOne is trading 4.15% up with no clear company-specific catalyst
BillionToOne is trading 4.15% higher at $101.94 on October 15, 2026, with no clear company-specific announcement explaining the move. - The latest company...
BillionToOne's Cancer Test Clears a Major Hurdle — But Can the Stock Price Catch Up to the Science?
Shares of BillionToOne barely budged at $94.30 despite the company announcing that its liquid biopsy cancer detection test cleared every primary and secondary...
BillionToOne Reports Positive Pivotal Results for Cancer Detection Test
BillionToOne, Inc. announced positive topline results from a pivotal registrational trial of its liquid biopsy test for early cancer detection. The study met...
🟢 BillionToOne is trading 4.03% up
BillionToOne is trading at $98.25, up 4.03%, with no clear catalyst identified for the gain. - No clear company-specific catalyst explaining the October 14...
🔴 BillionToOne is trading 4% down
BillionToOne is trading 4.02% lower at $94.15; no clear company-specific catalyst for the October 12 move surfaced in reviewed coverage. - The latest company...
🟢 BillionToOne rises 4.9% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 BillionToOne is trading 4% down with no clear company-specific catalyst
BillionToOne is trading 4.01% down at $91.91 on October 8, 2026; no clear company-specific catalyst has been identified. - Its latest announcement, published...
🔴 BillionToOne is trading 5% down today as equities fall, oil and Treasury yields rise
BillionToOne is trading at $95.00, down 4.94%, amid broader market pressure. - On October 7, 2026, equities fell, oil and Treasury yields rose, and investors...
🔴 BillionToOne is trading 5% down; no confirmed company-specific catalyst
BillionToOne is trading 5.24% down at $103.34 on October 6, 2026, with no confirmed company-specific announcement explaining the decline. - Recent coverage...
🔴 BillionToOne is trading 10.14% down with no confirmed catalyst identified
BillionToOne is trading 10.14% down at $106.20 on September 30, 2026, with no clear company-specific announcement or confirmed catalyst for the decline found...
🔴 BillionToOne is trading 4.7% down; immediate catalyst remains unclear
BillionToOne is trading at $112.64, down 4.68%, as its immediate catalyst remains unclear. - No clear new company-specific announcement explaining the...